Long medical device and method of manufacturing same

Abstract

To provide an elongated medical instrument on which a hydrogel film is formed using a simpler method.SOLUTION: An elongated medical instrument comprises a base material and a swollen gel film that covers the base material, wherein the swollen gel film comprises a polymer (a1) that includes a polymer unit having a betaine structure and a polymer unit having a carboxyl group (excluding the polymer unit having the betaine structure).SELECTED DRAWING: Figure 1

Description

[Technical Field]

[0001] The technology disclosed herein relates to elongated medical devices and methods for manufacturing the same. [Background technology]

[0002] In general, medical devices and the like that are inserted into the body, such as into a blood vessel, are required to have good insertability into the blood vessel, etc., and good operability within the blood vessel, etc. For this reason, for example, in the case of guidewires and catheters as long medical devices, a hydrophilic polymer or the like is applied to the surface of the guidewire to impart good lubricity to the surface of the guidewire, thereby ensuring good insertability and operability.

[0003] On the other hand, surface-modifying additive compositions containing oligomeric or polymeric additives formed from two or more of zwitterionic monomers or polyalkylene glycol monomers, silicone or fluorocarbon monomers, or combinations thereof, or alkyl-substituted methacrylate, acrylate, acrylamide, or vinyl monomers, or combinations thereof, are known as polymer compositions for coating on elongated medical devices. The coating is achieved by applying the surface-modifying additive composition to the medical device by dip coating or the like. Furthermore, carboxybetaine monomers have been disclosed as one type of zwitterionic monomer (see, for example, Patent Document 1). [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Special Publication No. 2018-524029 Summary of the Invention [Problem to be solved by the invention]

[0005] To ensure the lubricity of the surface of a long medical device or the like, a highly biocompatible hydrogel film may be formed on the surface. However, conventional methods for forming a hydrogel film include complex steps, such as adding a crosslinking agent to a hydrophilic monomer to produce a crosslinked hydrophilic polymer, or applying a hydrophilic polymer and then irradiating it with UV light to produce a crosslinked hydrophilic polymer. Furthermore, methods using crosslinking agents or the like may require a step of removing unreacted crosslinking agent to maintain performance aspects such as biocompatibility. Therefore, there is a need for a simpler method for forming a hydrogel film on the surface of a long medical device or the like, without these complex steps, and for providing a long medical device on which such a hydrogel film is formed.

[0006] Furthermore, the challenge of providing a simpler method for forming a hydrogel film on the surface of a long medical device, and a long medical device with such a hydrogel film formed on it, is not limited to medical devices that are inserted into the body, such as into blood vessels, but is a challenge common to medical devices that require lubricity and other substrates in general.

[0007] This specification discloses a technique that can solve the above-mentioned problems. [Means for solving the problem]

[0008] The technology disclosed in this specification can be realized, for example, in the following forms.

[0009] (1) The elongated medical device disclosed herein comprises a substrate and a swollen gel film covering the substrate. The swollen gel film contains a polymer (a1) that includes a polymer unit having a betaine structure and a polymer unit having a carboxyl group (excluding the polymer unit having the betaine structure). This elongated medical device has good lubricity and can form a swollen gel film by heating alone, without using a crosslinking agent.

[0010] (2) In the above-mentioned long medical device, the polymerized unit having a betaine structure may include a polymerized unit having an ester-bonded betaine structure.

[0011] (3) In the above-mentioned elongated medical device, the swollen gel film may have a swelling degree of 180% or more and 900% or less.

[0012] (4) In the above-mentioned long medical device, the swollen gel membrane may be configured so that the molar ratio of polymer units having a betaine structure to polymer units having a carboxyl group in the polymer (a1) is 80:20 to 60:40.

[0013] (5) In the above-described elongated medical device, the substrate may be a guidewire or a catheter.

[0014] (6) The method for producing a long medical device disclosed in the present specification includes a coating step of applying a coating agent to a substrate and a forming step of heating the coating agent to form a swollen gel film, wherein the coating agent is a polymer containing a polymerization unit having an ester-bonded betaine structure and a dispersion term δD of 10 to 24 MPa in the Hansen solubility parameters at 25°C. 1 / 2 , polarity term δP is 5~19MPa 1 / 2 , hydrogen bond term δH is 3 to 17 MPa 1 / 2 and contains water and an organic solvent having a boiling point higher than 100°C, and in the formation step, the swollen gel film is formed by hydrolysis of the ester bonds in the polymer. According to this method for producing a long medical device, the coating agent contains a polymer including polymerization units with an ester-bonded betaine structure, and an organic solvent that satisfies the Hansen solubility parameter and has a boiling point higher than 100°C, so that a swollen gel film can be successfully formed on a substrate without going through complicated steps.

[0015] (7) In the method for manufacturing the long medical device, the organic solvent may be at least one selected from N-methyl-2-pyrrolidone (NMP), dimethyl sulfoxide (DMSO), N,N-dimethylformamide (DMF), dimethylacetamide (DMA), diacetone alcohol (DAOH), and diethylene glycol monoethyl ether (EDG).

[0016] (8) In the method for producing the elongated medical device, the substrate may be a guidewire or a catheter, and the hydrolysis rate of the ester bonds in the polymer in the forming step may be 20% or more and 40% or less. This method for forming a swollen gel film allows the degree of swelling to be adjusted appropriately, making it possible to form a swollen gel film with lubricity suitable for a guidewire or a catheter. [Brief explanation of the drawings]

[0017] [Figure 1] FIG. 1 is an explanatory diagram illustrating a schematic configuration of a longitudinal section (YZ section) of a guidewire 100 according to the present embodiment. [Figure 2] FIG. 1 is an explanatory diagram conceptually illustrating a method for forming a swollen gel membrane GM in this embodiment. [Figure 3] A reaction formula showing the hydrolysis reaction in the method for forming the swollen gel film GM in this embodiment. DETAILED DESCRIPTION OF THE INVENTION

[0018] A. Implementation: A-1. Coating agent CA: The coating agent CA of this embodiment contains a polymer PA represented by the following general formula (1) and an organic solvent HS.

[0019] <Polymer PA> As represented by the following formula (1), the polymer PA of this embodiment contains a repeating unit of an ester-bonded betaine structure (hereinafter referred to as a "structural unit a1"). [ka] (In formula (1), R 1 is a hydrogen atom or a methyl group, and R 2 is a linear or branched alkylene group having 1 to 6 carbon atoms, and R 3 and R 4 are each independently an alkyl group having 1 to 4 carbon atoms, and R 5 is a linear or branched alkylene group having 1 to 4 carbon atoms, and Y is -COO - or -SO3 - and m is an integer of 1 or greater.) The proportion of the structural unit a1 in the polymer PA is, for example, 10 to 100 mol %.

[0020] Examples of the repeating unit of the ester-bonded betaine structure include repeating units derived from N-methacryloyloxyethyl-N,N-dimethylammonium-α-N-methylcarboxybetaine (GLBT), 3-{[2-(methacryloyloxy)ethyl]dimethylammonio}propionate (CEBMA), 3-{[2-(methacryloyloxy)ethyl]dimethylammonio}propane-1-sulfonate (SPBMA), etc. Among these, a repeating unit derived from N-methacryloyloxyethyl-N,N-dimethylammonium-α-N-methylcarboxybetaine (GLBT) is preferred.

[0021] As represented by the following general formula (2), the polymer PA may contain, in addition to the structural unit a1 represented by the above formula (1), a repeating unit derived from a hydroxyalkyl (meth)acrylate ester (hereinafter referred to as "structural unit a2"). [ka] (In formula (2), R 1 is a hydrogen atom or a methyl group, and R 2 is a linear or branched alkylene group having 1 to 6 carbon atoms, and R 3 and R 4 are each independently an alkyl group having 1 to 4 carbon atoms, and R 5is a repeating unit that is a linear or branched alkylene group having 1 to 4 carbon atoms, and R 6 is a hydrogen atom or a methyl group, and R 7 is an alkyl group having 1 to 4 carbon atoms and having a hydroxyl group bonded to at least one carbon atom, and Y is -COO - or -SO3 - where m and n each independently represent an integer of 1 or greater.) By including the structural unit a2, film-forming properties and adhesion to substrates are improved. The proportion of the structural unit a2 in the polymer PA is, for example, 0 to 90 mol %.

[0022] In addition to the structural unit a1 represented by the above formula (1), the polymer PA may also have a repeating unit of a betaine structure other than an ester bond (hereinafter referred to as "structural unit a4"). Examples of the structural unit a4 include a repeating unit represented by the following formula (3). [ka] (In formula (3), R 1 is a hydrogen atom or a methyl group, and R 2 is a linear or branched alkylene group having 1 to 6 carbon atoms, and R 3 and R 4 are each independently an alkyl group having 1 to 4 carbon atoms, and R 5 is a linear or branched alkylene group having 1 to 4 carbon atoms, and Y is -COO - or -SO3 - and m is an integer of 1 or greater.) The proportion of the structural unit a4 in the polymer PA is, for example, 0 to 90 mol %.

[0023] Examples of repeating units having a betaine structure other than the above-mentioned ester-bonded type include repeating units derived from monomers having an amide-bonded betaine structure, such as 2-{dimethyl[3-(2-methylprop-2-enamido)-propyl]ammonio}acetate (MAMCMB), 3-[(3-methacryloylamino-propyl)-dimethyl-ammonio]-propionate (MAMCEB), 3-[(3-acryloylamino-propyl)-dimethyl-ammonio]propane-1-sulfonate (SPBAM), and 3-[(3-methacryloylamino-propyl)-dimethyl-ammonio]propane-1-sulfonate (SPBMAM).

[0024] That is, the polymer PA may be a homopolymer having the structural unit a1 represented by the above formula (1) as a single repeating unit, or may be a copolymer having the structural unit a1 and the structural unit a2 represented by the above formula (2), or may further be a polymer having a structural unit based on another monomer. When the polymer is a copolymer, the polymer PA may be any of a random copolymer, block copolymer, alternating copolymer, and graft copolymer of the structural unit a1 and the structural unit a2.

[0025] The polymer PA may further contain at least one structural unit having a hydrophilic structure, from the viewpoint of easily improving the hydrophilicity and water swelling property of the film to be formed. Examples of the hydrophilic structure in the structural unit having a hydrophilic structure include at least one structure selected from the group consisting of an amide structure (e.g., a (meth)acrylamide structure), an alkylene oxide structure, and a lactam structure (e.g., an α-lactam (three-membered ring), a β-lactam (four-membered ring), a γ-lactam (five-membered ring), a δ-lactam (six-membered ring)). Specific examples of monomers having an amide structure include (meth)acrylamide and N,N-dimethyl(meth)acrylamide. Specific examples of monomers having an alkylene oxide structure include ethylene glycol and methoxyethylene glycol. Specific examples of monomers having a lactam structure include N-vinyl-2-caprolactam, N-vinylpyrrolidone, and N-vinylpiperidone.

[0026] When the polymer PA further contains a structural unit having a hydrophilic structure, the proportion of the structural unit having a hydrophilic structure, based on all structural units of the polymer PA, is preferably 20 mol% or more, more preferably 30 mol% or more, and even more preferably 40 mol% or more, from the viewpoint of easily improving the hydrophilicity and water-swellability of the formed film. Also, based on all structural units of the polymer PA, it is preferably 60 mol% or less, more preferably 55 mol% or less, and even more preferably 50 mol% or less, from the viewpoint of easily improving the water resistance and adhesion to the substrate of the formed film.

[0027] In the coating agent CA of this embodiment, the polymer PA is represented by, for example, the following formula (4). [ka] (In formula (4), m and n each independently represent an integer of 1 or more.)

[0028] That is, in this embodiment, the polymer PA is, for example, a random copolymer containing, as the structural unit a1, a repeating unit derived from N-methacryloyloxyethyl-N,N-dimethylammonium-α-N-methylcarboxybetaine (CMB) and, as the structural unit a2, a repeating unit derived from 2-hydroxypropyl methacrylate (HPMA). In this embodiment, the molar ratio of CMB to HPMA in the polymer PA is, for example, 90:10 to 10:90, and preferably 60:40 to 40:60. In this embodiment, the molecular weight of the polymer PA is, for example, 10,000 or more and 2,000,000 or less, e.g., about 100,000.

[0029] The polymer PA contained in the coating agent CA of this embodiment may contain 2-hydroxyethyl methacrylate (HEMA) instead of HPMA in the above formula (4), or may be a three-dimensional copolymer containing HPMA and HEMA. Furthermore, the polymer PA may contain other repeating units in addition to the structural units a1 and a2. Examples of other repeating units include polyethylene glycol (PEG), methoxyethyl acrylate (MEA), n-butyl methacrylate (BMA), and 4-methacryloyloxybenzophenone (BEMA).

[0030] <Organic Solvent HS> By dissolving the polymer PA in the organic solvent HS, the fluidity of the coating agent CA (specifically, the polymer PA) can be ensured even in a high-temperature environment, and as a result, the swollen gel film GM described below can be successfully formed. Details will be explained later.

[0031] The organic solvent HS of this embodiment has a dispersion term ΔD of 10 to 24 MPa in the Hansen solubility parameter at 25°C. 1 / 2 , polarity term δP is 5~19MPa 1 / 2 , hydrogen bond term δH is 3 to 17 MPa 1 / 2 For example, the hydrogen bond term δH of the Hansen solubility parameter is 17 MPa. 1 / 2 If the hydrogen bond parameter δH is less than 3 and the polar parameter δP is less than 5, the polymer PA will not exhibit adequate miscibility with water and may even become soluble in water, making it difficult for a gel structure to form from the polymer PA. As a result, it will be difficult to improve the water resistance and swelling properties of the resulting film. Furthermore, if the polymer PA is a polymer containing the structural unit a1, the polymer PA will not hydrolyze as described below, making it difficult for a gel structure to form. If the hydrogen bond parameter δH is less than 3 and the polar parameter δP is less than 5, the polymer PA will not exhibit adequate miscibility with water and may even separate, making it difficult for a gel structure to form from the polymer PA.

[0032] The dispersion term δD is 10 to 24 MPa. 1 / 2 and preferably 12 to 20 MPa1 / 2 and more preferably 15 to 19 MPa 1 / 2 The polarity term ΔP is 5 to 19 MPa. 1 / 2 and preferably 8 to 17 MPa 1 / 2 and more preferably 10 to 15 MPa 1 / 2 The hydrogen bond term δH is 3 to 17 MPa. 1 / 2 , and preferably 5 to 14 MPa 1 / 2 and more preferably 7 to 13 MPa. 1 / 2 is.

[0033] The Hansen solubility parameter of the organic solvent HS may be the value listed in the calculation software Hansen Solubility Parameter in Practice (H SPiP, manufacturer: Charles M. Hansen). When the coating agent CA contains one organic solvent, the Hansen solubility parameter of the organic solvent should be within the above range. When two or more organic solvents are contained, at least one of the organic solvents should satisfy the above Hansen solubility parameter.

[0034] The Hansen solubility parameters of the organic solvent HS are the dispersion term δD, the polar term δP, and the hydrogen bonding term δH, as follows: √((δD-17) 2 +(δP-12) 2 +(δH-10) 2 )≦7 It is preferable that the following relationship is satisfied. The value calculated by this formula is preferably 7 or less. The above formula indicates that the organic solvent belongs to a Hansen sphere with an interaction radius R=7.0, with the central values ​​being dispersion term δD=17, polar term δP=12, and hydrogen bond term δH=10.

[0035] The organic solvent HS of this embodiment is a high-boiling organic solvent having a boiling point of more than 100°C, more preferably 110°C or higher, even more preferably 115°C or higher, even more preferably 150°C or higher, and particularly preferably 180°C or higher. The organic solvent HS of this embodiment is more preferably a polar solvent, and even more preferably an aprotic polar solvent. From the viewpoint of the manufacturability and availability of the resulting water-swellable film, the boiling point of the organic solvent HS is preferably 205°C or lower. When the coating agent CA contains multiple types of organic solvents, at least one of the organic solvents should have the above boiling point.

[0036] The coating agent CA contains water in addition to the polymer PA and the organic solvent HS. When the coating agent CA contains water, the coating agent CA includes a mixed solvent of water and the organic solvent HS and the polymer PA. The concentration of the polymer PA relative to the coating agent CA is, for example, preferably 1 wt% or more, more preferably 2 wt% or more, and even more preferably 3 wt% or more. It is also preferably 20 wt% or less, more preferably 15 wt% or less, and even more preferably 10 wt% or less. It is even more preferably about 5 wt%. The proportion of the organic solvent HS in the mixed solvent is, for example, preferably 5 wt% or more, more preferably 10 wt% or more, and even more preferably 15 wt% or more. It is also preferably 50 wt% or less, more preferably 45 wt% or less, and even more preferably 40 wt% or less. It is even more preferably about 15 wt%.

[0037] A-2. Swollen gel membrane GM: The swollen gel film GM of this embodiment contains a polymer PB represented by the following general formula (5). More specifically, the swollen gel film GM is a hydrogel film swollen with water, and its swelling degree is, for example, 180% to 900%, preferably 300% to 800%. The swelling degree is calculated as d2 / d1 × 100 (%), where d1 is the film thickness of the swollen gel film GM when it is thoroughly dried (e.g., dried to a water content of 0.1% by weight or less), and d2 is the film thickness of the swollen gel film GM when it is fully swollen. In this embodiment, the swollen gel film GM refers to a physically crosslinked gel.

[0038] <Polymer PB> As represented by the following formula (5), the polymer PB of this embodiment preferably contains the above-mentioned structural unit a1 and a repeating unit derived from (meth)acrylic acid (hereinafter referred to as "structural unit a3"). [ka] (In formula (5), R 1 is a hydrogen atom or a methyl group, and R 2 is a linear or branched alkylene group having 1 to 6 carbon atoms, and R 3 and R 4 are each independently an alkyl group having 1 to 4 carbon atoms, and R 5 is a linear or branched alkylene group having 1 to 4 carbon atoms, and Y is -COO - or -SO3 - and m and o are each independently an integer of 1 or greater.

[0039] As represented by the following general formula (6), the polymer PB may contain the structural unit a2 described above in addition to the structural unit a1 and structural unit a3 represented by the above formula (5). [ka] (In formula (6), R 1 is a hydrogen atom or a methyl group, and R 2is a linear or branched alkylene group having 1 to 6 carbon atoms, and R 3 and R 4 are each independently an alkyl group having 1 to 4 carbon atoms, and R 5 is a repeating unit that is a linear or branched alkylene group having 1 to 4 carbon atoms, and R 6 is a hydrogen atom or a methyl group, and R 7 is an alkyl group having 1 to 4 carbon atoms and having a hydroxyl group bonded to at least one carbon atom, and Y is -COO - or -SO3 - wherein m, n, and o are each independently an integer of 1 or greater.

[0040] The polymer PB may not contain the structural unit a1 as long as it contains a polymerization unit having a betaine structure. For example, it may be a polymer containing the structural unit a4 and the structural unit a3 described above. A swollen gel film can be formed by the interaction between the structural unit a4 and the structural unit a3. Such a polymer PB can be obtained by using a polymer containing the structural unit a1 and the structural unit a4 as the polymer PA and hydrolyzing all of the ester-bonded betaine structures of the structural unit a1 to form the structural unit a3. Alternatively, it may be a polymer containing the structural unit a1, the structural unit a4, and the structural unit a3.

[0041] The polymer PB contained in the swollen gel film contains polymerized units having a betaine structure and polymerized units having a carboxyl group. In the polymer PB, the ratio of polymerized units having a betaine structure to polymerized units having a carboxyl group is preferably 90:10 to 10:90 (molar ratio), and more preferably 80:20 to 60:40 (molar ratio).

[0042] That is, the polymer PB may be a copolymer of the structural unit a1 and the structural unit a3, as represented by the above formula (5), or may be a copolymer having the structural unit a1, the structural unit a2, and the structural unit a3, as represented by the above formula (6), or may be a polymer having the structure represented by the above formula (5) or formula (6) and further containing the structural unit a4. Alternatively, the polymer PB may be a copolymer of the structural unit a4 and the structural unit a3, or a copolymer of the structural unit a4, the structural unit a2, and the structural unit a3, which does not contain the structural unit a1. The polymer PB may be any of a random copolymer, block copolymer, alternating copolymer, and graft copolymer containing the above structural units.

[0043] In the swollen gel film GM of this embodiment, the polymer PB is represented by, for example, the following formula (7). [ka] (In formula (7), m, n, and o each independently represent an integer of 1 or more.)

[0044] That is, in this embodiment, the polymer PB is a random copolymer that contains, for example, a repeating unit derived from N-methacryloyloxyethyl-N,N-dimethylammonium-α-N-methylcarboxybetaine (CMB) as the structural unit a1, a repeating unit derived from 2-hydroxypropyl methacrylate (HPMA) as the structural unit a2, and a repeating unit derived from methacrylic acid (MA) as the structural unit a3. In this embodiment, the molar ratio of CMB to HPMA to MA in the polymer PB is, for example, 47:50:3 to 40:50:10, and more preferably 45:50:5 to 43:50:7. In this embodiment, the molecular weight of the polymer PB is, for example, 10,000 or more and 2,000,000 or less.

[0045] The polymer PB contained in the swollen gel film GM of this embodiment may contain 2-hydroxyethyl methacrylate (HEMA) instead of HPMA in the above formula (7), or may be a three-dimensional copolymer containing HPMA and HEMA. Furthermore, the polymer PB may contain other repeating units in addition to the structural units a1, a2, and a3. Examples of other repeating units include polyethylene glycol (PEG), methoxyethyl acrylate (MEA), n-butyl methacrylate (BMA), and 4-methacryloyloxybenzophenone (BEMA).

[0046] In this embodiment, the proportion of the polymer PB in the swollen gel film GM is, for example, preferably 1 wt % or more and 30 wt % or less, and more preferably 3 wt % or more and 20 wt % or less.

[0047] A-3. Guidewire 100: FIG. 1 is an explanatory diagram schematically illustrating the configuration of a guidewire 100 according to this embodiment. FIG. 1 shows the configuration of a longitudinal cross section (YZ cross section) of the guidewire 100. Note that a portion of the guidewire 100 is not shown in FIG. 1. In FIG. 1, the positive Z-axis direction is the tip end (distal side) that is inserted into the body, and the negative Z-axis direction is the base end (proximal side) that is manipulated by an operator such as a doctor. Although FIG. 1 shows the guidewire 100 as a whole in a linear shape that is approximately parallel to the Z-axis direction, the guidewire 100 is flexible enough to be bent.

[0048] For ease of explanation, in this specification, the guide wire 100 is assumed to be in the state shown in Figure 1, the Z-axis direction is referred to as the "axial direction of the guide wire 100" or simply as the "axial direction," and the direction of rotation around the Z-axis is referred to as the "circumferential direction of the guide wire 100" or simply as the "circumferential direction."

[0049] The guidewire 100 is a long medical device that is inserted into a blood vessel or the like to guide a catheter to a lesion (a narrowed or blocked area) in the blood vessel or the like. The total length of the guidewire 100 is, for example, about 1500 mm to 3000 mm, and the outer diameter of the guidewire 100 is, for example, about 0.5 to 1.2 mm.

[0050] The guidewire 100 includes a core shaft 10, a coil body 20, a distal joint 32, a proximal joint 34, and a resin portion 40 made of the swollen gel film GM. At least one of the core shaft 10, the coil body 20, the distal joint 32, and the proximal joint 34 is an example of a base material within the scope of the claims.

[0051] The core shaft 10 is a long member having a small diameter at its distal end and a large diameter at its proximal end. More specifically, the core shaft 10 is composed of a rod-shaped small diameter portion 11, a rod-shaped large diameter portion 13 located on the proximal end side of the small diameter portion 11 and having a larger diameter than the small diameter portion 11, and a tapered portion 12 located between the small diameter portion 11 and the large diameter portion 13 and having a gradually increasing diameter from the boundary with the small diameter portion 11 toward the boundary with the large diameter portion 13. The shape of the cross section (XY cross section) at each position of the core shaft 10 can be any shape, for example, a circle or a flat plate. The outer diameter of the large diameter portion 13 is, for example, about 0.2 to 0.6 mm.

[0052] The core shaft 10 is made of a known material, such as a metal material, more specifically, stainless steel (SUS302, SUS304, SUS316, etc.), Ni-Ti alloy, piano wire, nickel-chromium alloy, cobalt alloy, tungsten, etc. The core shaft 10 may be made entirely of the same material, or may have different portions made of different materials.

[0053] 1, coil body 20 is a coil-shaped member formed into a hollow cylinder by spirally winding wire, and is disposed so as to surround the outer periphery of core shaft 10. As a forming material for coil body 20, a known material is used, such as a metal material, more specifically, stainless steel (SUS302, SUS304, SUS316, etc.), Ni-Ti alloy, piano wire, nickel-chromium alloy, cobalt alloy, tungsten, etc.

[0054] The distal joint portion 32 is a member that joins the distal end of the core shaft 10 and the distal end of the coil body 20. That is, the distal end of the core shaft 10 and the distal end of the coil body 20 are fixed so as to be embedded inside the distal joint portion 32. The outer peripheral surface on the distal side of the distal joint portion 32 is a smooth surface (for example, a substantially hemispherical surface). Furthermore, the proximal joint portion 34 is a member that joins the core shaft 10 and the proximal end of the coil body 20 at a predetermined position between the proximal end and the distal end of the core shaft 10 along the axial direction. That is, the proximal end of the coil body 20 is fixed so as to be embedded inside the proximal joint portion 34.

[0055] Known materials are used as materials forming the distal joint portion 32 and the proximal joint portion 34, such as brazing material (aluminum alloy brazing, silver brazing, gold brazing, etc.), metal solder (Ag—Sn alloy, Au—Sn alloy, etc.), adhesive (epoxy adhesive, etc.), etc. In this embodiment, brazing material is used as the material forming the distal joint portion 32 and the proximal joint portion 34.

[0056] The resin portion 40 is made of resin and is a coating member that covers the outer circumferential surfaces of the coil body 20, the distal joint portion 32, and the proximal joint portion 34. The resin portion 40 is made of the swollen gel film GM described above. The thickness of the resin portion 40 is, for example, about 0.01 to 0.1 mm. The resin portion 40 is arranged approximately uniformly on the outer circumferential surface of the coil body 20, following the shape of the outer circumferential surface of the wire.

[0057] A-4. Method for forming swollen gel membrane GM: Next, an example of a method for forming a swollen gel film GM of this embodiment will be described. Fig. 2 is an explanatory diagram conceptually showing a method for forming a swollen gel film GM on a substrate. Note that Fig. 2 shows the configuration of a portion of a guidewire serving as the substrate. The method for forming the swollen gel film GM is also part of the method for manufacturing the guidewire 100.

[0058] First, a guidewire is prepared, which is composed of a core shaft 10, a coil body 20, a distal joint 32, and a proximal joint 34 (see FIG. 2(A)). Next, the coating agent CA described above is prepared. Specifically, the coating agent CA contains a polymer PA including a structural unit a1, which is a repeating unit of an ester-bonded betaine structure, and a structural unit a2, which is a repeating unit derived from a (meth)acrylic acid hydroxyalkyl ester, and an organic solvent HS. The coating agent CA is applied to the outer surface of the coil body 20 of the prepared guidewire and to the outer surfaces of the distal joint 32 and the proximal joint 34 (hereinafter also referred to as the "guidewire surface") (application step, see FIG. 2(B)). The method for applying the coating agent CA is not particularly limited, and examples thereof include a dip coating method and a spray method.

[0059] Next, the coating agent CA is heated at a temperature exceeding 100°C to form a swollen gel film GM (forming step; see FIG. 2(C)). More specifically, the swollen gel film GM is formed by hydrolysis of the ester bonds in the polymer PA contained in the coating agent CA. More specifically, the guidewire coated with the coating agent CA is dried in a hot-air circulating drying oven at a predetermined temperature for a predetermined time (e.g., 3 hours at 120°C), thereby hydrolyzing the ester bonds in the polymer PA. The hydrolysis rate of the ester bonds in the polymer PA in the forming step is, for example, 20% or more and 40% or less, from the viewpoint of obtaining a swollen gel film GM that combines good water retention and good lubricity. To achieve this hydrolysis rate, the hydrolysis temperature in the forming step can be, for example, 110°C or more, more preferably 115°C or more and 135°C or less, and the hydrolysis time can be, for example, 30 minutes to 5 hours. To achieve hydrolysis at such high temperatures, the organic solvent HS contained in the coating agent CA can be selected according to the hydrolysis temperature. Through the above steps, a swollen gel film GM (resin portion 40) can be formed on the surface of the guidewire (see FIG. 2(D)).

[0060] Thus, in the method for forming a swollen gel film GM of this embodiment, by using the coating agent CA, hydrolysis can be promoted by heating alone, without the need for a crosslinking agent typically used in hydrolysis reactions, to form a swollen gel film GM. The mechanism for forming a swollen gel film GM from the coating agent CA is described below. Note that, while the following describes a configuration in which the polymer PA contained in the coating agent CA has CMB as the structural unit a1 and HPMA as the structural unit a2, as represented by the above formula (4), the following mechanism also applies to polymer PAs in which the structural unit a1 and the structural unit a2 are any of the repeating units described above, and to polymer PAs that do not have the structural unit a2.

[0061] Figure 3 shows the hydrolysis reaction in the formation process described above. As described above, through this formation process, some of the CMB repeating units constituting the polymer PA are hydrolyzed, resulting in the production of polymer PB containing MA repeating units. That is, the hydrolysis of polymer PA produces polymer PB, which contains positively charged CMB repeating units and negatively charged MA repeating units within a single molecule. The carboxyl group in the MA repeating unit carries a high negative charge. Therefore, a strong electrostatic interaction is effectively induced between the positively charged betaine structure and the highly negatively charged carboxyl group, which is thought to have resulted in the gelation of polymer PB within each molecule.

[0062] It is also believed that the betaine structure and the carboxyl group are at least partially ampholyzed by a reaction such as that shown in the diagram below. [ka]

[0063] Therefore, it is thought that when a polymer containing polymerization units with an ester-bonded betaine structure is heated in the presence of the specific organic solvent HS contained in the coating agent CA and water, at a temperature above 100°C at which the ester bond moiety is hydrolyzed, the following interactions occur, a crosslinked structure derived from ampholyte is formed, and a water-swellable film is formed. [ka]

[0064] As described above, in this embodiment, the inclusion of the organic solvent HS in the coating agent CA allows for the successful formation of a swollen gel film GM from the coating agent CA. The ester bonds in the polymer PA contained in the coating agent CA are effectively hydrolyzed in a high-temperature environment (e.g., 110°C or higher). Therefore, the inclusion of the organic solvent HS in the coating agent CA allows for a high-temperature environment in which the ester bonds in the polymer PA can be effectively hydrolyzed while maintaining the fluidity of the coating agent CA (specifically, the polymer PA). As a result, hydrolysis can proceed uniformly both inside and outside the polymer PA molecule. Furthermore, by maintaining the fluidity of the coating agent CA in a high-temperature environment, the flexibility of the molecular chains constituting the polymer PB can be ensured in the polymer PB produced through hydrolysis. As a result, the betaine structure and the carboxyl group in the polymer PB can approach a level at which a strong electrostatic interaction can be induced, allowing gelation to proceed within the molecule. Therefore, the inclusion of the organic solvent HS in the coating agent CA allows for the uniform hydrolysis of the polymer PA, ultimately resulting in the formation of a swollen gel film GM with excellent lubricity.

[0065] A-5. Performance evaluation: Guidewire 100 provided with swollen gel film GM (resin portion 40) was subjected to performance evaluation for the following items. First, the method for producing samples S1 to S5 will be described.

[0066] <Sample S1> (Synthesis of polymer PA) First, 0.014 mol of CMB (Osaka Organic Chemical Industry Co., Ltd., product name: GLBT) and 0.014 mol of HPMA (Fujifilm Wako Pure Chemical Industries, Ltd., product name: hydroxypropyl methacrylate) were added to 20 g of a mixed solution (water:ethanol ratio: 50:50) and dissolved. While stirring the resulting solution, 0.00026 mol of ammonium persulfate (Tokyo Chemical Industry Co., Ltd., product name: APS) was further added and dissolved. The resulting solution was reacted with stirring in a thermostatic bath at 60 °C for 20 hours to obtain a polymer solution containing CMB-HPMA copolymer. The resulting polymer solution was added dropwise to a 20-fold volume of acetone solution to recrystallize, filtered, and vacuum-dried to obtain a polymer solid (polymer PA). The number-average molecular weight of the resulting polymer PA was approximately 100,000. The number-average molecular weight of the polymer PA was measured using nuclear magnetic resonance (NMR) and gel permeation chromatography (GPC).

[0067] (Preparation of Coating Agent CA) A 5 wt% polymer solution was prepared by dissolving the polymer PA in a mixed solution (distilled water:NMP ratio 70:30) containing an organic solvent HS (manufactured by Fujifilm Wako Pure Chemical Industries, product name: 1-methyl-2-pyrrolidone (NMP)). For this performance evaluation, 0.3 wt% carboxymethyl cellulose (CMC, Sigma-Aldrich, product name: CMC ultra high viscosity) was added as a thickener to increase the viscosity of the polymer solution, and the mixture was stirred to prepare the coating agent CA. The amount of CMC added can be adjusted appropriately depending on the thickness of the swollen gel film GM to be formed on the substrate. More specifically, CMC may not be added, or a low-viscosity agent may be added instead of CMC. Alternatively, other thickeners may be added instead of CMC.

[0068] (Method for forming swollen gel membrane GM) The above-described coating agent CA was applied by dip coating to a guidewire including a core shaft 10, a coil body 20, a distal joint 32, and a proximal joint 34. The coating agent CA was then hydrolyzed at a heating temperature of 120°C for three hours. Specifically, the coating agent CA was dried for three hours in a hot air circulating oven at 120°C to form a swollen gel film GM (resin portion 40) on the guidewire, producing sample S1.

[0069] The polymer decomposition rate was calculated by quantifying the amount of HCMB [2-(2-hydroxyethyldimethylammonio)acetate] produced by hydrolysis of the ester-bonded betaine structure using liquid chromatography, and applying the amount of HCMB (mol) and the theoretical amount of GLBT (mol, charged amount) in the polymer to the following formula. Decomposition rate (%) = HCMB (mol) / theoretical GLBT in polymer (mol) × 100

[0070] <Samples S2 to S5> Samples S2 to S5 were prepared under the same conditions as sample S1, except that the preparation conditions were changed as shown in Table 1 below.

[0071] <Performance evaluation results> Table 1 below shows the evaluation results for the lubricity and film strength of samples S1 to S5. Lubricity was evaluated by immersing each of samples S1 to S5 in physiological saline, then pinching and rubbing the swollen gel film GM portion between the fingertips. A slippery feel was rated as lubricity "A" (high lubricity), and a rough feel was rated as lubricity "B" (low lubricity). Furthermore, when the presence of the swollen gel film GM was not confirmed, the lubricity was rated as lubricity "C" (no swollen gel film). Film strength was also evaluated by measuring the resistance value. A lower resistance value indicates a higher film strength. Resistance measurements were performed by sandwiching each of samples S1 to S5 between an upper urethane roller (Misumi, AXFM-D25-L15-V8-N) and a lower stainless steel plate (SUS304, 30 mm x 30 mm), adjusting the weight of the urethane roller to 100 g, and measuring the resistance load when pulling the sample with a force gauge while running water around it. Durability was evaluated by measuring the initial resistance and the resistance after 50 cycles and comparing the two. The initial resistance was the resistance value obtained from the first measurement, and the resistance after 50 cycles was the resistance value obtained from the 50th measurement of 50 consecutive similar measurements.

[0072] [Table 1]

[0073] In the lubricity evaluation results, Samples S1 to S3 were rated "A" (high lubricity), while Sample S4 was rated "B" (low lubricity). As mentioned above, Samples S1 to S3 were heated at 120°C, while Sample S4 was heated at a lower temperature of 80°C. This suggests that the low heating temperature used to dry the swollen gel film GM in Sample S4 resulted in insufficient hydrolysis of the polymer PA contained in the coating agent CA. In other words, compared to Samples S1 to S3, in which the polymer PA was fully hydrolyzed, Sample S4 lacked the repeating unit (structural unit a3) derived from MA in the polymer PB after hydrolysis. As a result, the electrostatic interaction with the betaine structure in the polymer PB was low, which is thought to have prevented gelation from progressing.

[0074] The lubricity evaluation result for sample S5 was "C" (no swollen gel film). In other words, the presence of a swollen gel film on the guidewire was not confirmed for sample S5. This is thought to be because the coating agent for sample S5 did not contain the organic solvent HS, and therefore a high-temperature environment capable of satisfactorily hydrolyzing the ester bonds in polymer PA could not be achieved. In other words, gelation of polymer PB did not proceed, and the coating agent was thought to have been washed away when immersed in the physiological saline solution.

[0075] In the evaluation of film strength, samples S1 to S3, in which a good swollen gel film GM was formed, showed lower initial resistance values ​​and lower resistance values ​​at the 50th time than samples S4 and S5. In other words, samples S1 to S3 were confirmed to have higher film strength than samples S4 and S5. Furthermore, samples S1 to S3 were able to achieve resistance values ​​at the 50th time that were equivalent to the initial resistance values. In other words, the swollen gel film GM in samples S1 to S3 had good film strength and durability. Therefore, samples S1 to S3 were confirmed to have good lubricity, as well as good film strength and durability.

[0076] A-6. Advantages of this embodiment: As described above, the coating agent CA of this embodiment is a polymer PA containing a polymerization unit (structural unit a1) having an ester-bonded betaine structure, and a coating agent CA having a dispersion term ΔD of 10 to 24 MPa in the Hansen solubility parameter at 25°C. 1 / 2 , polarity term δP is 5~19MPa 1 / 2 , hydrogen bond term δH is 3 to 17 MPa 1 / 2and an organic solvent HS, which is an organic solvent having a boiling point above 100°C. The inclusion of the organic solvent HS in the coating agent CA of this embodiment allows for the successful formation of a swollen gel film GM from the coating agent CA. More specifically, the ester bonds in the polymer PA contained in the coating agent CA are successfully hydrolyzed in a high-temperature environment (e.g., 110°C or higher). Therefore, the inclusion of the organic solvent HS in the coating agent CA of this embodiment allows for a high-temperature environment in which the ester bonds in the polymer PA can be successfully hydrolyzed while maintaining the fluidity of the coating agent CA (specifically, the polymer PA). As a result, hydrolysis can proceed uniformly both inside and outside the polymer PA molecule. Furthermore, the coating agent CA of this embodiment can maintain the fluidity of the coating agent CA in a high-temperature environment, thereby ensuring the flexibility of the molecular chains constituting the polymer PB in the polymer PB produced through hydrolysis. Here, the polymer PB contains, within each molecule, a polymerization unit (structural unit a1) having a positively charged ester-bonded betaine structure and a negatively charged (meth)acrylic acid polymerization unit (structural unit a3). Furthermore, the carboxyl group contained in the (meth)acrylic acid polymerization unit (structural unit a3) bears a high negative charge. As described above, in the coating agent CA of this embodiment, the flexibility of the molecular chains constituting the polymer PB can be ensured, so that the positively charged betaine structure and the highly negatively charged carboxyl group in the polymer PB can approach a level at which a strong electrostatic interaction can be induced. This allows gelation to proceed within the molecules of the polymer PB. Therefore, according to the coating agent CA of this embodiment, since it contains the organic solvent HS, the hydrolysis of the polymer PA can proceed uniformly without the need for complicated processes, in other words, simply by heating at a temperature above 100°C, and thus a swollen gel film GM with excellent lubricity can be formed.Furthermore, the coating agent CA of this embodiment can be applied to the surface of a substrate (such as the coil body 20 of the guidewire 100) in a relatively low viscosity state, and therefore a swollen gel film GM can be formed that is prevented from detaching from the surface, even on the surface of a medical device with a complex surface shape, such as the guidewire 100.

[0077] In the coating agent CA of this embodiment, the organic solvent HS has a dispersion term ΔD of 10 to 24 MPa in the Hansen solubility parameter at 25°C. 1 / 2 , polarity term δP is 5~19MPa 1 / 2 , hydrogen bond term δH is 3 to 17 MPa 1 / 2 The organic solvent HS is an organic solvent having a boiling point higher than 100°C, and is particularly at least one selected from N-methyl-2-pyrrolidone (NMP), dimethyl sulfoxide (DMSO), N,N-dimethylformamide (DMF), dimethylacetamide (DMA), diacetone alcohol (DAOH), and diethylene glycol monoethyl ether (EDG). By using an aprotic polar solvent with a relatively high boiling point (e.g., 150°C or higher) as the organic solvent HS, the fluidity of the coating agent CA can be better maintained in the high-temperature environment. Therefore, the coating agent CA of this embodiment can more effectively and uniformly hydrolyze the polymer PA, thereby forming a swollen gel film GM with excellent lubricity.

[0078] The swollen gel film GM of this embodiment contains a polymer PB containing a polymerization unit (structural unit a1) having an ester-bonded betaine structure and a (meth)acrylic acid polymerization unit (structural unit a2). That is, according to the swollen gel film GM of this embodiment, the polymer PB contained in the swollen gel film GM contains, within one molecule, a polymerization unit (structural unit a1) having a positively charged ester-bonded betaine structure and a negatively charged (meth)acrylic acid polymerization unit (structural unit a3). Furthermore, the carboxyl group contained in the (meth)acrylic acid polymerization unit (structural unit a3) carries a high negative charge. Therefore, in the swollen gel film GM of this embodiment, a strong electrostatic interaction is effectively induced between the positively charged betaine structure and the highly negatively charged carboxyl group within each molecule constituting the polymer PB, thereby maintaining a favorable gelation state within each molecule.

[0079] The guidewire 100 of this embodiment is coated with the above-mentioned swollen gel film GM. Therefore, according to the guidewire 100 of this embodiment, it is possible to provide a guidewire 100 having a swollen gel film GM in which a good gelation state is maintained within each molecule.

[0080] The method for forming a swollen gel film GM of this embodiment includes a coating step of applying a coating agent CA onto a substrate, and a formation step of heating the coating agent CA at a temperature above 100°C to form a swollen gel film GM. The coating agent CA includes a polymer PA containing polymerization units (structural units a1) having an ester-bonded betaine structure, and an organic solvent HS having a boiling point above 100°C. In the formation step, the swollen gel film GM is formed by hydrolysis of the ester bonds in the polymer PA. According to the method for forming a swollen gel film GM of this embodiment, the coating agent CA includes a polymer PA containing polymerization units (structural units a1) having an ester-bonded betaine structure, and an organic solvent HS having a boiling point above 100°C, so that the swollen gel film GM can be successfully formed on the substrate without going through complicated steps.

[0081] In the method for forming a swollen gel film GM of this embodiment, the substrate is a guidewire. Furthermore, in the formation process, the hydrolysis rate of the ester bonds in the polymer PB is 20% or more and 40% or less. According to the method for forming a swollen gel film GM of this embodiment, the degree of swelling can be adjusted to an appropriate level, and therefore a swollen gel film GM with lubricity suitable for the guidewire 100 can be formed.

[0082] [Reference example (resin compositions 1 to 16)] A polymer solution was obtained by synthesizing polymer PA in the same manner as described above, except that GLBT, HPMA, and MAA were dissolved in water in a molar ratio of 43:50:7, with a total monomer concentration of 10%. The viscosity-average molecular weight of the resulting polymer was 100,000. The polymer solution thus obtained was mixed with NMP in a mass ratio of 1:0.15 to obtain a resin composition. The mass ratio of the copolymer, organic solvent, and water in the resin composition was copolymer:organic solvent:water = 8.7:13.0:78.3.

[0083] Resin compositions 5-2 to 5-16 were obtained in the same manner as in the synthesis of polymer PA, except that in the resin composition containing the copolymer obtained above (shown as resin composition 5-1 in Table 2), each solvent shown in Table 2 was used instead of NMP. The insoluble film-forming ability, water resistance, and water swelling properties of these resin compositions were measured in the same manner as above. The results are shown in Table 2.

[0084] (insoluble film-forming) The resin composition was spread on a Teflon (registered trademark)-coated tray and then dried for 3 hours at 85° C. using a commercially available hot air dryer. 90 parts of water was added to 10 parts of the obtained copolymer solid, and the mixture was stirred at room temperature for 30 minutes and then allowed to stand for 24 hours. The state of the solution was evaluated according to the following criteria. A: The solution is clear B: There is residual material in the solution, or the solution becomes cloudy.

[0085] (Water resistance visual evaluation) 2.5 parts of the resin composition was spread on a Teflon (registered trademark) coated tray (10 cm x 10 cm) and left for 3 hours in an atmosphere at 125°C to obtain a cured product. The cured product was peeled off from the tray, and 2 parts of the peeled cured product was placed in a container, 98 parts of water was added, and the mixture was left to stand at room temperature for 24 hours. The state of the solution was then visually inspected and evaluated according to the following criteria. Note that evaluation results shown in parentheses are predicted values. The same applies to other evaluations described below. A: The cured product remains in a swollen state. B: The cured product is dissolved or remains in an unswollen state.

[0086] (Water swelling visual evaluation) Two parts of the cured product obtained in the same manner as for water resistance described above were placed in a container, and 98 parts of water were added. The mixture was allowed to stand at room temperature for 24 hours, after which the state of the solution was visually inspected and evaluated according to the following criteria. A: The cured product remains in a swollen state. B: The cured product is dissolved or remains in an unswollen state.

[0087] [Table 2]

[0088] B. Variations: In the above embodiment, the substrate coated with the swollen gel film GM may be a medical device other than the guidewire 100, or may be another substrate that requires good lubricity.

[0089] In the above embodiment, a guidewire has been described as an example of an elongated medical device, but the technology disclosed in this specification can be similarly applied to other elongated medical devices, such as catheters. Elongated medical devices will be described below.

[0090] Long medical devices: The long medical device of the present invention can be a medical device that is inserted into the body. Specifically, the long medical device of the present invention can be, for example, a long medical device whose outer periphery is made of metal, or a long medical device whose outer periphery is formed of a resin such as urethane, and a swollen gel film as described above is formed on the surface of the substrate. Particularly suitable forms of the long medical device of the present invention include, for example, a guidewire or a catheter. Specifically, for example, a guidewire whose outer periphery is made of metal, or a catheter having a hollow shaft whose outer periphery is made of a resin such as polyurethane, can be used as the substrate.

[0091] The catheter of the present disclosure is not particularly limited, and can be applied to any catheter, for example, a guiding catheter, a penetration catheter, a microcatheter, a balloon catheter, a foreign body removal catheter, an angiography catheter, a bile duct catheter, a urethral catheter, an endoscope, a dilator, etc. The guidewire of the present disclosure is also not particularly limited, and can be applied to any guidewire, for example, a PCI guidewire for coronary artery treatment, a PTA guidewire for lower limb vascular treatment, an IVR guidewire for peripheral vascular treatment, an INR guidewire for cerebrovascular treatment, a CAG guidewire for angiography, etc.

[0092] More specifically, the elongated medical device of this embodiment can employ various configurations, for example, as shown in the following (a) to (e). The swollen gel film in the following (a) to (e) is a swollen gel film containing polymer (a1) described herein, which contains polymerization units having a betaine structure and polymerization units having a carboxyl group. Furthermore, the material for forming the coating layer and tubular member described below is preferably a resin, such as polyamide, polyimide, modified polyolefin, polyvinyl alcohol, polyurethane, polyurea, polyester, polyether, polylactic acid, and resins combining these.

[0093] (a) A guide wire comprising a linear core wire, a coating layer provided on at least a portion of the outer periphery of the core wire, and a swollen gel film formed on the surface of the coating layer. (b) A guide wire comprising a linear core wire, a coil layer in which wire is spirally wound around at least a portion of the outer periphery of the core wire, and a swollen gel film formed on the surface of the coil layer. (c) A guide wire comprising: a linear core wire; a coil layer in which wire is spirally wound around at least a portion of the outer periphery of the core wire; a coating layer provided on the outer periphery of the coil layer; and a gel film formed on the surface of the coating layer. (d) A catheter comprising a tubular member and a swollen gel membrane formed on the surface of the tubular member. (e) A catheter comprising a tubular member, a balloon disposed at one end of the tubular member, and a swollen gel membrane formed on the surface of the balloon.

[0094] However, the elongated medical device of this embodiment may have a configuration different from the above (a) to (e), and may be a elongated medical device other than a guidewire or a catheter. It is sufficient that the elongated medical device has the above-mentioned swollen gel film on at least a portion of its surface. [Explanation of symbols]

[0095] 10: Core shaft 11: Thin diameter section 12: Tapered section 13: Thick diameter section 20: Coil body 32: Distal joint section 34: Proximal joint section 40: Resin section 100: Guidewire CA: Coating agent GM: Swollen gel film HS: Organic solvent PA: Polymer PB: Polymer

Claims

1. An elongated medical device comprising a substrate and a swollen gel film covering the substrate, the swollen gel film comprises a polymer (a1) including a polymer unit in which a group having a betaine structure is ester-bonded to a carboxyl group located on a side chain, and a polymer unit having a carboxyl group (excluding the polymer unit having the betaine structure); the swollen gel film is such that the molar ratio of polymerized units having a betaine structure to polymerized units having a carboxyl group in the polymer (a1) is 80:20 to 60:40; Long medical devices.

2. 10. The elongated medical device of claim 1, The swollen gel film has a swelling degree of 180% or more and 900% or less. Long medical devices.

3. 3. The elongated medical device according to claim 1 or claim 2, The substrate is a guidewire or a catheter. Long medical devices.

4. A method for manufacturing an elongated medical device, comprising: a coating step of applying a coating agent onto a substrate; and a forming step of forming a swollen gel film by heating the coating agent, The coating agent is a polymer including a polymerization unit having an ester-bonded betaine structure; In the Hansen solubility parameter at 25°C, the dispersion term δD is 10 to 24 MPa. １／２ , polarity term δP is 5 to 19 MPa １／２ , hydrogen bond term δH is 3 to 17 MPa １／２ an organic solvent having a boiling point greater than 100°C; water, In the forming step, the swollen gel membrane is formed by hydrolysis of the ester bond in the polymer, In the forming step, the hydrolysis rate of the ester bond in the polymer is 20% or more and 40% or less. A method for manufacturing long medical devices.

5. 5. The method for manufacturing an elongated medical device according to claim 4, The organic solvent is at least one selected from N-methyl-2-pyrrolidone (NMP), dimethyl sulfoxide (DMSO), N,N-dimethylformamide (DMF), dimethylacetamide (DMA), diacetone alcohol (DAOH), and diethylene glycol monoethyl ether (EDG). A method for manufacturing long medical devices.

6. A method for manufacturing the elongated medical device according to claim 4 or claim 5, comprising: The substrate is a guidewire or a catheter. A method for manufacturing long medical devices.

Images